Brind.

Patient Capital Management highlighted Tempus AI in its strategy on July 18, 2025.

1 report, 1 independent Updated Jul 18

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Tempus

Keep exploring

The entities involved

Tempus
biotechnology company based in Chicago, Illinois
- Tempus is scheduled to participate in a conference in New York City on September 4, 2025.Sun 01:41
- Tempus AI, led by Eric Lefkofsky, is acquiring Paige to enhance its digital pathology datasets.Sat 00:42

Coverage

Newest first; wire copies grouped

Jul 18Insider MonkeyDo You Believe in the Growth Potential of Tempus AI (TEM)? Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” second-quarter 2025 investor